April 12, 2005 David Karp Chief Financial Officer Chemokine Therapeuties Corp. Vancouver, BC, V6T 1Z3 Canada VIA CAMPUS MAIL Dear Mr. Karp, Re: Amendment to License Agreement between UBC and Chemokine Therapeutics Corporation dated September 22, 1999...License Agreement • April 26th, 2005 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
This letter agreement is to amend the subject of the License. The parties hereby agree to amend the License by making the following changes:
